A new book, “A New Deal for Cancer: Lessons from a 50-year War,” highlights the progress against cancer in the United States over the past half century and what may lie ahead. In a collection of essays, leading oncology experts, including doctors, policymakers, and academics, examine how policy, politics, and law can and should help advance progress against cancer, and how the obstacles in the path of continued progress can be dismantled.

One essay, “U.S. Federal Agencies: Advancing Cancer Research and Care Through Improved Coordination and Efficiency,” was written by the American Society of Clinical Oncology’s (ASCO) former Chief Medical Officer (CMO) Richard L. Schilsky, FSCT, FASCO, FACP, MD; current ASCO Associate Director, Science and Research Policy, Shimere Williams Sherwood, PhD; and ASCO Division Director, Policy & Advocacy, Shelagh Foster, JD. The essay summarizes the roles of the key federal agencies that impact cancer care and describes areas where agency jurisdictions overlap, and opportunities for increased efficiencies and collaborations.

The book looks at the nation’s progress since the National Cancer Act was signed into law on December 23, 1971, by President Richard Nixon who declared “a national commitment for the conquest of cancer.”

“A New Deal for Cancer” was edited by Abbe Gluck, Alfred M. Rankin Professor of Law and Faculty Director of the Solomon Center for Health Law and Policy at Yale Law School and Professor of Medicine at Yale School of Medicine, and Dr. Charles Fuchs, global head of product development for oncology and hematology at Roche and Genentech and former Director of Yale Cancer Center.

The book is now available for purchase.

Bookmark ASCO in Action for news, advocacy, and analysis on cancer policy.